PRECISEMAB
PrecisemAb is a Biotechnology Research company that provides antibody drug therapy using antibody lock technology for patients.
PRECISEMAB
Social Links:
Industry:
Biotechnology Health Care Therapeutics Wellness
Founded:
2021-01-01
Address:
Kaohsiung, T'ai-wan, Taiwan
Country:
Taiwan
Website Url:
http://www.precisemab.com.tw
Total Employee:
1+
Status:
Active
Contact:
+886 7 3111 577
Similar Organizations
AbTis
AbTis is a biotechnology company that provides antibody-drug conjugation technology and solubilization.
Bio Tree Biotechnology
Bio Tree Biotechnology is a biotechnology company that specializes in food supplement creation business.
Tavros Therapeutics
Tavros Therapeutics is an emerging biotechnology company that discovers and develops therapies for cancer.
Current Employees Featured
Founder
Official Site Inspections
http://www.precisemab.com.tw
Unable to get host informations!!!
More informations about "PrecisemAb"
PrecisemAb Biotech|A Pioneer of Antibody Lock - 碩準生技股份有 …
PrecisemAb's disease-directed Antibody Lock makes antibody drugs become the safest. We deeply believe that "High safety is the key making therapeutic efficacy meaningful." …See details»
PrecisemAb | Disease-directed Antibody Masking
PrecisemAb | Disease-directed Antibody Masking. English. ... The talents that make the impossible possible. Contact Us +886-7-311-1577 [email protected] ...See details»
Our Team - 碩準生技股份有限公司 - PrecisemAb
PrecisemAb is established by Tian Lu Cheng, the chair professor of Kaohsiung Medical University, Dr. YunChi and Dr. Yi-An who both have over 10 years of experiences in antibody engineering area. PrecisemAb also have professional …See details»
PrecisemAb 碩準生技|最令人安心的抗體專家
碩準生技研發「萬能抗體鎖平台」，依據抗體藥物需求，客製化設計抗體結 合位的屏蔽結構(抗體鎖)，使抗體藥物僅在蛋白酶過度表現的疾病區才恢復抗體功 能，有效提升抗體的疾病區選擇 …See details»
PrecisemAb - Crunchbase Company Profile & Funding
PrecisemAb is a Biotechnology Research company that provides antibody drug therapy using antibody lock technology for patients. Kaohsiung, T'ai-wan, Taiwan; 1-10; ... Contact Email …See details»
PrecisemAb Company Profile 2024: Valuation, Funding & Investors …
Www.precisemab.com.tw. Ownership Status. Privately Held (backing) Financing Status. Venture Capital-Backed. Corporate Office. Room 1207, 12F, First Teaching Building; ... PrecisemAb’s …See details»
PrecisemAb Biotech Co., Ltd - Drug pipelines, Patents, Clinical trials ...
Explore PrecisemAb Biotech Co., Ltd with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Neoplasms, Nervous System Diseases, Immune System ...See details»
PrecisemAb Biotech Co., Ltd. - dns.biopharm.org.tw
Welcome to visit Taiwan Pavilion at booth No. 1917 & 1817 in Bio 2024! BPIPO is honored to organize Taiwan delegation with over 50 companies and organizations in new drug, CDMO, …See details»
PrecisemAb 碩準生技|關於我們
PrecisemAb 由高雄醫學大學鄭添祿講座教授、呂韻綺博士、鄭以安博士，帶領團隊共同建立。 深耕抗體工程領域長達 25 年，鄭添祿教授成功研發獨步全球的「抗體鎖技術」，可有效提升抗體藥物對疾病區域的選擇性，並降低藥物副作用， …See details»
PrecisemAb - Company Profile - Tracxn
Oct 8, 2024 PrecisemAb - Developer of antibody therapies for cancer treatment. Founded by YunChi Lu, YiAn Cheng and 1 other in the year 2021. PrecisemAb has 760 competitors.See details»
PrecisemAb Biotech Co.,Ltd. - Taiwan Tech Arena｜Empowering …
PrecisemAb Biotech Co.,Ltd. HOME Our Startups 碩準生藉由抗體鎖技術(多國專利)將抗體藥物用於專一治療疾病(癌症或免疫性疾病)，藉此改善病患在服用其藥物之副作用的問題。See details»
PrecisemAb Biotech Co., Ltd. - LinkedIn
PrecisemAb Biotech Co., Ltd. | 259 位 LinkedIn 關注者。We are committed to changing the world to be better by creating safer and disease-directed Lock-antibody therapy. | Noticing that …See details»
About-Our History - 碩準生技股份有限公司 - PrecisemAb
Our name, PrecisemAb, consists of ‘‘Precise’’ and ‘‘mAb’’ which reflects our mission to enhance the safety of antibody drugs via our Universal Antibody Lock technology. ... +886-7-311-1577 …See details»
Taiwan Startup PrecisemAb Continues Progress Towards Vision
Jul 29, 2022 The Universal Antibody Lock technology will give patients more of a choice. TAIPEI, July 29, 2022 /PRNewswire/ -- PrecisemAb Biotech, a biotechnology research …See details»
Taiwan Startup PrecisemAb Continues Progress Towards Vision of …
Jul 29, 2022 The Universal Antibody Lock technology will give patients more of a choice TAIPEI, July 29, 2022 /PRNewswire/ -- PrecisemAb Biotech, a biotechnology research company based …See details»
Taiwan Startup PrecisemAb Continues Progress Towards Vision
Jul 29, 2022 The Universal Antibody Lock technology will give patients more of a choice. TAIPEI, July 29, 2022 /PRNewswire/ -- PrecisemAb Biotech, a biotechnology research …See details»
Our Technology-PrecisemAb | A Pioneer of Anti-body Lock
Noticing that antibody drugs can effectively cure diseases but at the same time cause severe adverse effects because of on-target toxicity, PrecisemAb, just like our name "Precise + mAb", …See details»
Taiwanese startup PrecisemAb announces progress towards vision …
Aug 2, 2022 PrecisemAb copies parts of the antibody structure but not entirely to produce drugs that can eliminate as many side effects as possible, resulting in more refined antibody …See details»
Newsroom-PrecisemAb | A Pioneer of Anti-body Lock
The PrecisemAb team is deeply committed to continuing Professor Cheng’s mission and honoring his legacy. We will focus on advancing innovative drug development, strengthening …See details»
Newsroom-PrecisemAb | A Pioneer of Anti-body Lock
PrecisemAb wins the Championship in Zhan-Guo-Ce Startup Competition 2022-01-19 15:34:27. Report Date: 2021/07/22. Congratulations on PrecisemAb's winning of 2021 Zhan-Guo-Ce …See details»